1. New Products

New Products

Cat. No. Product Name Target Research Area Added Chemical Structure
HY-128744 Phosphonoacetic acid

Endogenous Metabolite

2019-09 Phosphonoacetic acid
HY-107785 2-Deoxy-2-sulfoamino-D-glucose sodium

Endogenous Metabolite

2019-09 2-Deoxy-2-sulfoamino-D-glucose sodium
HY-33212 D-N-Acetylgalactosamine

Endogenous Metabolite

2019-09 D-N-Acetylgalactosamine
HY-107826 5α-Cholestan-3-one

Endogenous Metabolite

2019-09 5α-Cholestan-3-one
HY-112537B D-Glucose 6-phosphate sodium

Endogenous Metabolite

2019-09 D-Glucose 6-phosphate sodium
HY-N1423B Glycocholic acid (hydrate)

Endogenous Metabolite

2019-09 Glycocholic acid (hydrate)
HY-124009A L-Cysteic acid (monohydrate)

Endogenous Metabolite

2019-09 L-Cysteic acid (monohydrate)
HY-128740 Mesoxalate sodium (monohydrate)

Endogenous Metabolite

2019-09 Mesoxalate sodium (monohydrate)
HY-Y0519 Pyrimidine

Endogenous Metabolite

2019-09 Pyrimidine
HY-112314 AZD0424

Src; Apoptosis

Cancer

2019-09 AZD0424
HY-14804A Tasisulam sodium

Apoptosis

Cancer

2019-09 Tasisulam sodium
HY-120323 DRI-C21045

Others

Inflammation/Immunology

2019-09 DRI-C21045
HY-114233 MC-GGFG-DX8951

Drug-Linker Conjugates for ADC

Cancer

2019-09 MC-GGFG-DX8951
HY-128946 CL2A-SN-38

ADC Linker

Cancer;

Inflammation/Immunology

2019-09 CL2A-SN-38
HY-B1816 Zaprinast

Phosphodiesterase (PDE); CXCR

Cardiovascular Disease;

Neurological Disease

2019-09 Zaprinast
HY-12863 CPI-0610

Epigenetic Reader Domain

Cancer

2019-09 CPI-0610
HY-100581 CORM-3

NF-κB

Inflammation/Immunology

2019-09 CORM-3
HY-19744 T6167923

MyD88

Inflammation/Immunology

2019-09 T6167923
HY-19939S2 (R)-VX-984

Others

Others

2019-09 (R)-VX-984
HY-14804 Tasisulam

Apoptosis

Cancer

2019-09 Tasisulam